Literature DB >> 14963699

99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: methodological considerations-reply.

Anna Płachcińska, Jacek Kuśmierek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14963699     DOI： 10.1007/s00259-004-1471-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.

Authors:  C Decristoforo; S J Mather; W Cholewinski; E Donnemiller; G Riccabona; R Moncayo
Journal:  Eur J Nucl Med       Date:  2000-09

2.  Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication.

Authors:  Anna Płachcińska; Renata Mikołajczak; Helmut R Maecke; Ewa Młodkowska; Jolanta Kunert-Radek; Andrzej Michalski; Katarzyna Rzeszutek; Józef Kozak; Jacek Kuśmierek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-05       Impact factor: 9.236

3.  Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a pilot study.

Authors:  Anna Plachcinska; Renata Mikolajczak; Helmut Maecke; Ewa Mlodkowska; Jolanta Kunert-Radek; Andrzej Michalski; Katarzyna Rzeszutek; Jozek Kozak; Jacek Kusmierek
Journal:  Cancer Biother Radiopharm       Date:  2004-04       Impact factor: 3.099
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.